Personal information

Websites & social links

King's College London profile page

Other IDs

Scopus Author ID: 56008678200

Activities

Collapse all

Employment (7)

King's College London: London, GB

Employment
Source: check_circle
King's College London

King's College London: London, London, GB

2020 to present | Professor of Pharmacology & Neuroscience (Pharmacology and Neuroscience)
Employment
Source: Self-asserted source
Susan Duty

King's College London: London, London, GB

2004 to 2012 | Senior Lecturer in Pharmacology (Pharmacology )
Employment
Source: Self-asserted source
Susan Duty

King's College London: London, London, GB

1995 to 2004 | Lecturer in Pharmacology (Pharmacology )
Employment
Source: Self-asserted source
Susan Duty

University of Manchester: Manchester, Manchester, GB

1993 to 1995 | Post-doctoral research associate (Anatomy)
Employment
Source: Self-asserted source
Susan Duty

University of Sydney: Sydney, NSW, AU

1991 to 1993 | Post-doctoral research associate (Physiology )
Employment
Source: Self-asserted source
Susan Duty

University of Manchester: Manchester, Manchester, GB

1990 to 1991 | Post doctoral research associate (Pharmacology )
Employment
Source: Self-asserted source
Susan Duty

Education and qualifications (2)

University of Manchester: Manchester, Manchester, GB

1987 to 1990 | PhD (Pharmacology)
Education
Source: Self-asserted source
Susan Duty

University of Manchester: Manchester, Manchester, GB

1984 to 1987 | BSc Physiology and Pharmacology (Pharmacology)
Education
Source: Self-asserted source
Susan Duty

Funding (1)

Boosting endogenous fibroblast growth factor 20 levels in the nigrostriatal tract to achieve neuroprotection and repair in Parkinson’s

Source: Self-asserted source
Susan Duty via DimensionsWizard

Works (39)

Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson’s disease

npj Parkinson's Disease
2023-04-26 | Journal article | Author
DOI: 10.1038/s41531-023-00510-3
SOURCE-WORK-ID:

2e8a4c53-62a2-477a-8b1b-d4ab6e58232a

EID:

2-s2.0-85154616512
Contributors: Yazead Buhidma; Carl Hobbs; Marzia Anna Maria Malcangio; Susan Duty
Source: check_circle
King's College London

A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson’s Disease

Pharmaceutics
2022-07 | Journal article | Author
DOI: 10.3390/pharmaceutics14071335
SOURCE-WORK-ID:

0749cd74-8e00-4e25-82d6-eff84d602b7b

EID:

2-s2.0-85133228710
Contributors: Emily Clarke; Pawel Stocki; Elizabeth H. Sinclair; Aziz Gauhar; Edward J.R. Fletcher; Alicja Krawczun-Rygmaczewska; Susan Duty; Frank S. Walsh; Patrick Doherty; Julia Lynn Rutkowski
Source: check_circle
King's College London

Drug repurposing strategies of relevance for Parkinson’s disease

Pharmacology Research and Perspectives
2021-08 | Journal article | Author
DOI: 10.1002/prp2.841
SOURCE-WORK-ID:

d19da654-795e-4dab-a59d-3733eb0cd40b

EID:

2-s2.0-85112064151

PMID: 34309236
Contributors: Edward J.R. Fletcher; Thomas Kaminski; Gareth Williams; Susan Duty
Source: check_circle
King's College London

Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease

Nature Parkinson's Journal
2020-12-01 | Journal article | Author
DOI: 10.1038/s41531-019-0104-6
SOURCE-WORK-ID:

435a0da7-a6b7-4e0b-b8ae-ac3c0f6fb5f1

EID:

2-s2.0-85084784857
Contributors: Susan Duty; Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri
Source: check_circle
King's College London

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats

Frontiers in Neuroscience
2020-09-15 | Journal article | Author
DOI: 10.3389/fnins.2020.567222
SOURCE-WORK-ID:

145aadf4-7580-4f6a-bc8b-4041516433d4

PMID: 33041762
EID:

2-s2.0-85091694672
Contributors: Edward J R Fletcher; Clare J Finlay; Ana Amor Lopez; William Crum; Anthony Christopher Vernon; Susan Duty
Source: check_circle
King's College London

Antiparkinsonian effects of a metabotropic glutamate receptor 4 agonist in MPTP-treated marmosets

Journal of parkinsons disease
2020-07-28 | Journal article | Author
SOURCE-WORK-ID:

1c5347e6-d91c-4a0d-9614-b107efdcf130

EID:

2-s2.0-85089128468
Contributors: Lizzie Mann; Michael Jackson; Louise Lincoln; Ria Fisher; SARAH ROSE; Susan Duty
Source: check_circle
King's College London

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease

BMC NEUROSCIENCE
2019-12-20 | Journal article | Author
DOI: 10.1186/s12868-019-0543-3
SOURCE-WORK-ID:

ead67ad8-75b7-4fc3-ab69-66416085e924

PMID: 31862005
EID:

2-s2.0-85076976963
Contributors: Edward J R Fletcher; Prof. Lawrence DF Moon; Susan Duty
Source: check_circle
King's College London

Pain in Parkinson's disease

Current Opinion in Neurology
2019-08-01 | Journal article | Author
DOI: 10.1097/WCO.0000000000000711
SOURCE-WORK-ID:

edbbbcba-e8ef-4939-a90e-8081eee0c467

EID:

2-s2.0-85069260626

PMID: 31260418
Contributors: Katarina Rukavina; Valentina Leta; Carolina Sportelli; Yazead Buhidma; Susan Duty; Marzia Anna Maria Malcangio; Kallol Ray Chaudhuri
Source: check_circle
King's College London

Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.

Scientific Reports
2019-06-06 | Journal article | Author
DOI: 10.1038/s41598-019-44803-1
SOURCE-WORK-ID:

71382b48-1a5f-472d-84c5-8200b5427b3c

EID:

2-s2.0-85066939020
Contributors: Susan Duty; Edward Joseph Richard Fletcher; Gareth Williams; Patrick Doherty; Aran Jamieson
Source: check_circle
King's College London

Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner

Neuropharmacology
2018-07-15 | Journal article | Author
DOI: 10.1016/j.neuropharm.2018.04.017
SOURCE-WORK-ID:

acbccd3c-03db-467d-9f44-09500b924768

EID:

2-s2.0-85048004735
Contributors: Susan Duty; Eugene L Boshoff; Edward J Fletcher
Source: check_circle
King's College London

Animal models of movement disorders

Movement Disorders Curricula
2017-01-01 | Book chapter | Author
DOI: 10.1007/978-3-7091-1628-9_2
SOURCE-WORK-ID:

0c59adf9-4a8a-41d6-9729-e112f2963ce9

EID:

2-s2.0-85086958116

Part of ISBN: 9783709116289
Part of ISBN: 9783709116272
Contributors: Susan Duty; Peter Jenner
Source: check_circle
King's College London

Therapeutic potential of targeting glutamate receptors in Parkinson’s disease

Journal of neural transmission (Vienna, Austria : 1996)
2014-08-01 | Journal article | Author
DOI: 10.1007/s00702-014-1176-4
SOURCE-WORK-ID:

9eff9744-a127-4484-a003-96301e95ddd8

EID:

2-s2.0-84925781042

PMID: 24557498
Contributors: Clare Finlay; Susan Duty
Source: check_circle
King's College London

Brain morphometry and the neurobiology of levodopa-induced dyskinesias

Frontiers in Neurology
2014-06-11 | Journal article | Author
DOI: 10.3389/fneur.2014.00095
SOURCE-WORK-ID:

24f4454d-85c7-495a-a3ef-3dc1c2e93f0f

PMID: 24971074
EID:

2-s2.0-84904416529
Contributors: Clare J Finlay; Susan Duty; Anthony Christopher Vernon
Source: check_circle
King's College London

Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

Neuropharmacology
2012-12 | Journal article | Author
DOI: 10.1016/j.neuropharm.2012.07.029
SOURCE-WORK-ID:

57679e1e-7242-4ada-ae4e-290d8a6267cc

WOSUID:

000309624300008

EID:

2-s2.0-84866051700
Contributors: Isobel J. Sleeman; Eugene L. Boshoff; Susan Duty
Source: check_circle
King's College London

Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease

CNS Drugs
2012-12 | Journal article | Author
DOI: 10.1007/s40263-012-0016-z
SOURCE-WORK-ID:

7d12f1fb-14a0-450c-aa4f-02e993275a67

PMID: 23114872
EID:

2-s2.0-84873417885
Contributors: Susan Duty
Source: check_circle
King's College London

Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson’s disease

British Journal of Pharmacology
2012-08 | Journal article | Author
DOI: 10.1111/j.1476-5381.2012.01943.x
SOURCE-WORK-ID:

b3386be0-1aee-4b4b-955d-ad5e2b28dac4

EID:

2-s2.0-84864472836
Contributors: Matt Betts; Michael J O'Neill; Susan Duty
Source: check_circle
King's College London

Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation

BMC NEUROSCIENCE
2012-04-05 | Journal article | Author
DOI: 10.1186/1471-2202-13-38
SOURCE-WORK-ID:

4a6d4dfe-bc25-4c63-8193-c18accc776f6

WOSUID:

000304006000001

EID:

2-s2.0-84859322860
Contributors: Marica Carbone; Susan Duty; Marcus Rattray
Source: check_circle
King's College London

Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata

British Journal of Pharmacology
2012-02 | Journal article | Author
DOI: 10.1111/j.1476-5381.2011.01515.x
SOURCE-WORK-ID:

20e279bb-a0e6-4c26-8549-6a592bf56c3d

WOSUID:

000299469600002

EID:

2-s2.0-84856316283
Contributors: M. Broadstock; P. J. Austin; M. J. Betts; Susan Duty
Source: check_circle
King's College London

Riluzole elevates GLT-1 activity and levels in striatal astrocytes

Neurochemistry International
2012-01 | Journal article | Author
DOI: 10.1016/j.neuint.2011.10.017
SOURCE-WORK-ID:

f49be696-ede9-414e-a286-e95093bc24d8

WOSUID:

000300254200004

EID:

2-s2.0-83455235343
Contributors: Marica Carbone; Susan Duty; Marcus Rattray
Source: check_circle
King's College London

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

British Journal of Pharmacology
2011-10 | Journal article | Author
DOI: 10.1111/j.1476-5381.2011.01426.x
SOURCE-WORK-ID:

f158f310-705a-4fe0-9c26-e65c6730b824

WOSUID:

000295218600017

EID:

2-s2.0-80052533576
Contributors: Susan Duty; Peter Jenner
Source: check_circle
King's College London

Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease (vol 160, pg 1741, 2010)

British Journal of Pharmacology
2011-07 | Journal article | Author
DOI: 10.1111/j.1476-5381.2011.01549.x
SOURCE-WORK-ID:

d5bd5f93-fbe2-41f8-a213-af5b3b927399

WOSUID:

000292098700022

EID:

2-s2.0-79959766955
Contributors: P. J. Austin; M. J. Betts; M. Broadstock; M. J. O'Neill; S. N. Mitchell; Susan Duty
Source: check_circle
King's College London

Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease

British Journal of Pharmacology
2010-09 | Journal article | Author
DOI: 10.1111/j.1476-5381.2010.00882.x
SOURCE-WORK-ID:

b3c9d4f6-d33e-428a-b092-64c359b08c14

WOSUID:

000281210400002

EID:

2-s2.0-77954330278
Contributors: Susan Duty
Source: check_circle
King's College London

Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease

British Journal of Pharmacology
2010-08 | Journal article | Author
DOI: 10.1111/j.1476-5381.2010.00820.x
SOURCE-WORK-ID:

497a7210-6bef-4923-9e63-f11b74d1fe75

WOSUID:

000279616400017

EID:

2-s2.0-77954340961
Contributors: P. J. Austin; M. J. Betts; M. Broadstock; M. J. O'Neill; S. N. Mitchell; Susan Duty
Source: check_circle
King's College London

Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo

European Journal of Pharmacology
2008-02-02 | Journal article | Author
DOI: 10.1016/j.ejphar.2007.10.030
SOURCE-WORK-ID:

819e646d-d9f5-4d34-96f6-8452e1f7585e

WOSUID:

000252983100013

EID:

2-s2.0-37749040514
Contributors: N MacInnes; Susan Duty
Source: check_circle
King's College London

Nicotine, but neither the alpha(4)beta(2) ligand RJR2403 nor an alpha 7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

Neuropharmacology
2006-09 | Journal article | Author
DOI: 10.1016/j.neuropharm.2006.04.015
SOURCE-WORK-ID:

9ad207ed-8ad5-438b-be08-635c3d76c01e

WOSUID:

000240811900011

EID:

2-s2.0-33747360178
Contributors: N P Visanji; M J O'Neill; Susan Duty
Source: check_circle
King's College London

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and a6 and b3 nicotine acetylcholine receptor subumit mRNA in the substantia nigra pars compacta of the rat

Neuropharmacology
2006-01 | Journal article | Author
DOI: 10.1016/j.neuropharm.2005.07.013
SOURCE-WORK-ID:

ce1be879-d545-4faf-96ec-f2d662a7a471

WOSUID:

000235261400004

EID:

2-s2.0-30344452297
Contributors: N P Visanji; S N Mitchell; M J O'Neill; Susan Duty
Source: check_circle
King's College London

Locomotor effects of imidazoline I-2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway

British Journal of Pharmacology
2004-12 | Journal article | Author
DOI: 10.1038/sj.bjp.0706019
SOURCE-WORK-ID:

58d2a8ff-63de-4ebb-9604-b2e6e0afa9ce

WOSUID:

000225967300006

EID:

2-s2.0-11244252922
Contributors: N MacInnes; Susan Duty
Source: check_circle
King's College London

Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat

British Journal of Pharmacology
2004-01 | Journal article | Author
DOI: 10.1038/sj.bjp.0705566
SOURCE-WORK-ID:

3af40c08-1229-408f-a053-1fe8e237911c

WOSUID:

000188926300004

EID:

2-s2.0-1242341372
Contributors: N MacInnes; M J Messenger; Susan Duty
Source: check_circle
King's College London

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease

Experimental Neurology
2003-10-01 | Journal article | Author
DOI: 10.1016/S0014-4886(03)00064-5
SOURCE-WORK-ID:

7ea85531-a68c-4e8a-b909-b6b529ad7e93

WOSUID:

000185724600022

EID:

2-s2.0-0141672033
Contributors: B Henry; Susan Duty; S H Fox; A R Crossman; J M Brotchie
Source: check_circle
King's College London

Changes in GABA(B) receptor mRNA expression in the rodent basal ganglia and thalamus following lesion of the nigrostriatal pathway

Neuroscience
2003-09-15 | Journal article | Author
DOI: 10.1016/S0306-4522(03)00418-4
SOURCE-WORK-ID:

521f8fb3-52db-40a6-a661-6cf2cd807d15

WOSUID:

000187447900013

EID:

2-s2.0-0041632332
Contributors: T Johnston; Susan Duty
Source: check_circle
King's College London

GABA(B) receptor agonists reverse akinesia following intranigral or intracerebroventricular injection in the reserpine-treated rat

British Journal of Pharmacology
2003-08 | Journal article | Author
DOI: 10.1038/sj.bjp.0705372
SOURCE-WORK-ID:

75d827ec-ddb7-42e1-bc24-93b457108040

WOSUID:

000184795700014

EID:

2-s2.0-0141428772
Contributors: T Johnston; Susan Duty
Source: check_circle
King's College London

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease

Pharmacology Biochemistry and Behavior
2002 | Journal article | Author
DOI: 10.1016/S0091-3057(02)00842-0
SOURCE-WORK-ID:

767b7219-bee9-4664-8c10-b7dcf848dc57

WOSUID:

000177501500021

EID:

2-s2.0-0035996544
Contributors: T K Murray; M J Messenger; M A Ward; S Woodhouse; D J Osborne; Susan Duty; M J O'Neill
Source: check_circle
King's College London

Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract

Neuropharmacology
2002-08 | Journal article | Author
DOI: 10.1016/S0028-3908(02)00090-4
SOURCE-WORK-ID:

34e1e02e-59c7-4c50-82d5-09921eae0a68

WOSUID:

000178238700015

EID:

2-s2.0-0036669625
Contributors: M J Messenger; L G Dawson; Susan Duty
Source: check_circle
King's College London

The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration

CURRENT DRUG TARGETS CNS AND NEUROLOGICAL DISORDERS
2002-08 | Journal article | Author
DOI: 10.2174/1568007023339166
SOURCE-WORK-ID:

2163e240-50b4-4062-ac0f-27d9268fd172

EID:

2-s2.0-0011359002
Contributors: M J O'Neill; T K Murray; V Lakics; N P Visanji; Susan Duty
Source: check_circle
King's College London

Changes in GABAB1A and GABAB2 receptor gene expression in the basal ganglia and thalamus of rats with a nigrostriatal tract lesion

British Journal of Pharmacology
2000 | Journal article | Author
SOURCE-WORK-ID:

dd9e38e2-2d2d-42f4-8c5c-4fbbaed82ff0
Contributors: T Johnston; P Jenner; Susan Duty
Source: check_circle
King's College London

The 5HT(1B) receptor agonist, CP-93129, inhibits [H-3]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat

British Journal of Pharmacology
2000 | Journal article | Author
DOI: 10.1038/sj.bjp.0703526
SOURCE-WORK-ID:

25e6c9d8-345e-4eac-88b7-460b0327b27c

WOSUID:

000088880100026

EID:

2-s2.0-0033842669
Contributors: A Chadha; C Sur; J Atack; Susan Duty
Source: check_circle
King's College London

The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat

British Journal of Pharmacology
2000 | Journal article | Author
DOI: 10.1038/sj.bjp.0703105
SOURCE-WORK-ID:

c0383a92-7b75-4a1b-898e-76e5a80f7071

WOSUID:

000085249600017

EID:

2-s2.0-0033967160
Contributors: L Dawson; A Chadha; M Megalou; Susan Duty
Source: check_circle
King's College London

Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus

Neuroscience
2000-11 | Journal article | Author
DOI: 10.1016/S0306-4522(99)00413-3
SOURCE-WORK-ID:

a401c58c-cd6e-4db7-b79c-ccc1c36dc3cc

WOSUID:

000084071000013

EID:

2-s2.0-0032702244
Contributors: A Chadha; L G Dawson; P G Jenner; Susan Duty
Source: check_circle
King's College London

Changes in [H-3]zolpidem and [H-3]Ro 15-1788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesion

Brain Research
2000-04-17 | Journal article | Author
DOI: 10.1016/S0006-8993(00)02081-3
SOURCE-WORK-ID:

3ae34f3b-6483-4ead-ae76-f17118b6e648

WOSUID:

000086656100039

EID:

2-s2.0-0034678144
Contributors: A Chadha; O Howell; J R Atack; C Sur; Susan Duty
Source: check_circle
King's College London

Peer review (1 review for 1 publication/grant)

Review activity for Nature communications (1)
How many people are using ORCID?